Cleared Traditional

K011003 - SAFESTING AND SAFESTING HUB

K011003 is an FDA 510(k) clearance for SAFESTING AND SAFESTING HUB, manufactured by Diasol, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 16-day FDA review.

K011003 · Diasol, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2001
Decision
16d
Days
Class 2
Risk

K011003 is an FDA 510(k) clearance for the SAFESTING AND SAFESTING HUB. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Diasol, Inc. (North Hollywood, US). The FDA issued a Cleared decision on April 20, 2001 after a review of 16 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diasol, Inc. devices

FDA 510(k) Submission Details - K011003

510(k) Number K011003 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 2001
Decision Date April 20, 2001
Days to Decision 16 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
113d faster than avg
Panel avg: 129d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 513
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K011003.
SIMPLICITY SOFT QD SILVER INFUSION SET
K011580 · Sterling Medivations, Inc. · Jun 2001
SIMPLICITY WING INFUSION SET
K010886 · Sterling Medivations, Inc. · Apr 2001
SIMPLICITY SOFT QD EASY INFUSION SET
K010788 · Sterling Medivations, Inc. · Apr 2001
SIMPLICITY WINGED QD INFUSION SET
K010676 · Sterling Medivations, Inc. · Apr 2001
SIMPLICITY INFUSER INFUSION SET
K010647 · Sterling Medivations, Inc. · Apr 2001
SIMPLICITY SILVER SET SOFT INFUSION
K010846 · Sterling Medivations, Inc. · Apr 2001